This protocol summary has been amended based on NDAC- Vaccines (New Drug Advisory Committee on Vaccines) of Drugs Controller General of India (DCGI)'s recommendation to conduct this study as a Phase IV study instead of phase III, because the Rotarix liquid file application is considered as a line extension of Rotarix Lyophilized formulation.